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Introduction
Transforming growth factor beta (TGF-) is an important
suppressor factor in the adult liver, inhibiting hepatocyte DNA
synthesis and inducing active cell death (Rossmanith and Schulte-
Hermann, 2001). However, TGF- overexpression is frequently
observed in human hepatocellular carcinomas, suggesting that liver
tumour cells, as with many other tumour cells, can overcome the
suppressive effects of TGF- (Breuhan et al., 2006; Massagué,
2008). Indeed, in foetal rat hepatocytes and hepatoma cells, TGF-
 induces both cell death through a mitochondrial-dependent
mechanism, and a survival response through the activation of the
c-Src and epidermal growth factor receptor (EGFR) pathways
(Herrera et al., 2001; Park et al., 2004; Murillo et al., 2005; Caja
et al., 2007). Interestingly, cells that survive the apoptotic effects
of TGF- undergo epithelial-to-mesenchymal transition (EMT)
(Valdés et al., 2002; Caja et al., 2007). EMT is an important
physiological process during embryogenesis and wound healing
by which epithelial cells lose their polarity and cell-cell adhesion
molecules, subsequently expressing mesenchymal markers and
becoming motile with scattering properties (Thiery et al., 2009). A
closely related phenotypic conversion is also detected in fibrosis
and neoplasia, which is associated with disease progression (Lopez-
Novoa and Nieto, 2009). Members of the TGF- family can initiate
and maintain EMT in a variety of biological systems and
pathophysiological situations, particularly through activation of
major signalling pathways and transcriptional regulators integrated
in extensive signalling networks (Zavadil and Bottinger, 2005;
Heldin et al., 2009). Indeed, evidence points to the crosstalk
between the genetic programs that control TGF--induced growth
arrest and/or apoptosis and those that regulate EMT, as once the
cell has adopted a mesenchymal phenotype, it does not respond to
the TGF- suppressor effects (Valdés et al., 2002; Gal et al., 2008).
The Snail family of zinc-finger transcription factors are excellent
candidates to mediate the escape from the tumour suppressor
effects of TGF- as they are very potent inducers of EMT and
well-known targets of TGF- signalling in many cell types,
including hepatocytes (Spagnoli et al., 2000; Gotzmann et al.,
2002; Valdés et al., 2002; Thiery et al., 2009). In addition, Snail1
also confers resistance to the cell death induced either by the
withdrawal of survival factors or pro-apoptotic stimuli (Barrallo-
Gimeno and Nieto, 2005). Thus, we decided to analyze the role of
Snail1 in the activity of TGF- in the liver in order to assess its
contribution to the loss of TGF- tumour-suppressor effects.
Results
TGF--induced Snail expression in hepatocytes and
hepatoma cells requires the activation of the TGF-
receptor 1 and the NF-kappaB pathway
It is known that TGF- transiently induces Snail1 expression in
primary cultures of foetal rat hepatocytes (Valdés et al., 2002) (Fig.
1A). This effect can be impaired in the presence of SB431542 (Fig.
1B), a specific TGF- receptor 1 (TGFR1) inhibitor (Fig. 1C),
confirming the implication of this receptor in Snail1 induction.
TGF--induced intracellular signals appear to act directly on the
Snail1 promoter as the induction of Snail1 transcription did not
require de novo protein synthesis (Fig. 1D). Many of the
intracellular pathways examined did not appear to be implicated in
this process, including the phosphatidylinositol-3 kinase,
MEK/ERK, p38 and c-Jun-N-kinase pathways, as their inhibitors
had no effect on TGF--induced Snail1 upregulation
Snail1 suppresses TGF--induced apoptosis and is
sufficient to trigger EMT in hepatocytes
D. Lorena Franco1,*, Jèssica Mainez2,*, Sonia Vega1,*, Patricia Sancho2, Miguel M. Murillo2,3,
Cristina A. de Frutos1, Gaelle del Castillo3, Cristina López-Blau1, Isabel Fabregat2,3,‡ and M. Angela Nieto1,‡
1Instituto de Neurociencias (CSIC-UMH), 03550 San Juan de Alicante, Spain
2Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), Laboratori d’Oncologia Molecular, L’Hospitalet, 08907 Barcelona, Spain
3Universidad Complutense de Madrid, Facultad de Farmacia, Departamento de Bioquímica y Biología Molecular II, 28040 Madrid, Spain
*These authors contributed equally to this work
‡Authors for correspondence (ifabregat@idibell.cat; anieto@umh.es)
Accepted 28 June 2010
Journal of Cell Science 123, 3467-3477 
© 2010. Published by The Company of Biologists Ltd
doi:10.1242/jcs.068692
Summary
Although TGF- suppresses early stages of tumour development, it later contributes to tumour progression when cells become resistant
to its suppressive effects. In addition to circumventing TGF--induced growth arrest and apoptosis, malignant tumour cells become
capable of undergoing epithelial-to-mesenchymal transition (EMT), favouring invasion and metastasis. Therefore, defining the
mechanisms that allow cancer cells to escape from the suppressive effects of TGF- is fundamental to understand tumour progression
and to design specific therapies. Here, we have examined the role of Snail1 as a suppressor of TGF--induced apoptosis in murine
non-transformed hepatocytes, rat and human hepatocarcinoma cell lines and transgenic mice. We show that Snail1 confers resistance
to TGF--induced cell death and that it is sufficient to induce EMT in adult hepatocytes, cells otherwise refractory to this transition
upon exposure to TGF-. Furthermore, we show that Snail1 silencing prevents EMT and restores the cell death response induced by
TGF-. As Snail1 is a known target of TGF- signalling, our data indicate that Snail1 might transduce the tumour-promoting effects
of TGF-, namely the EMT concomitant with the resistance to cell death.
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(supplementary material Fig. S1). However, SN50, a specific
inhibitor of the nuclear translocation of p65, a functional subunit
of the nuclear factor-kappaB (NF-B) pathway, abolished the TGF-
-induced increase in Snail1 transcripts (Fig. 1E). Interestingly,
TGF- activated NF-B in foetal rat hepatocytes (Fig. 1F) and
overexpression of p65 induced Snail1 transcription, whereas
abrogation of the NF-B pathway by the IB super-repressor
prevented Snail induction by TGF- (Fig. 1G).
As we have previously published (Caja et al., 2007), TGF- can
also induce a full EMT in liver tumour cells. Indeed, EMT occurs
in FaO rat hepatoma cells concomitant with Snail1 induction,
involving the downregulation of E-cadherin expression and the
induction of vimentin expression and that of other cytoskeletal
markers (Fig. 2A; supplementary material Fig. S2). As in foetal rat
hepatocytes, TGF--induced Snail1 transcription does not appear
to involve the phosphatidylinositol-3 kinase, MEK/ERK, p38 and
c-Jun-N-kinase pathways (data not shown) and SN50 prevented
the increase in Snail1 expression, confirming that NF-B is required
(Fig. 2B). In agreement with this, knockdown of p65 with specific
siRNA (sip65-1) abolished TGF--induced Snail1 upregulation
(Fig. 2C). We used a second sequence to interfere with p65
expression, obtaining similar results (sip65-2; data not shown).
Because NF-B appeared to be necessary for TGF--mediated
Snail1 induction in hepatocytes, we assessed whether it directly
regulated Snail1 transcription. Two putative NF-B binding sites
were found in the Snail1 promoter that are conserved in the rat and
human genomes (supplementary material Fig. S3) and, hence, we
generated luciferase reporter constructs carrying the wild-type
mouse Snail1 promoter (–1000 pb) or a modified promoter in
which each or both of the two B-boxes was deleted (–672: B1
and –162: B2). When these constructs were transfected into FaO
rat hepatoma cells along with a CMV-p65 expression vector, it was
evident that although the B1 box was dispensable, the B2 was
required for p65 to regulate Snail1 promoter activity (Fig. 2D).
Chromatin immunoprecipitation analysis carried out with an anti-
p50 antibody confirmed that upon TGF- stimulation,
transcriptionally active NF-B (p65/p50) is recruited to the B2
box of the Snail1 promoter (Fig. 2E).
Snail1 downregulation enhances the apoptotic response
to TGF- in immortalized murine hepatocytes
To explore the contribution of Snail1 to the effects of TGF- in
hepatocytes, we used specific siRNAs to knockdown Snail1
expression. To favour the transfection efficiency, rather than using
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Fig. 1. TGF--induced Snail expression in hepatocytes requires the activation of TGF- receptor 1 and the NF-B pathway. (A)TGF- induces Snail1
expression in foetal rat hepatocytes analyzed by real time RT-PCR. Cells were maintained in the presence or absence of TGF- (2 ng/ml) for the times indicated.
(B)Expression of Snail1 analyzed by real time RT-PCR in hepatocytes incubated in the presence or absence of TGF- (2 ng/ml, 3 hours) and either untreated or
pretreated (1 hour before TGF- addition) with 10M SB431542. (C)Phosphorylation of Smad2 was analyzed in the presence or absence of TGF- (2 ng/ml, 1
hour) and/or 10M SB431542 (TGF- receptor 1 inhibitor). Protein extracts were collected to analyze pSmad2 in western blots. -actin was used as a loading
control. (D)As in B, but treated with 0.5g/ml of the protein synthesis inhibitor cycloheximide (CHX). (E)Inhibition of NF-B activity by incubation with SN50
impairs the activation of Snail1 transcription by TGF-. Foetal rat hepatocytes were pretreated with SN50 (50M, 1 hour) and then stimulated with TGF- (2
ng/ml) for 3 hours. Snail1 mRNA levels were analyzed by real time PCR. (F)TGF- activates NF-B in foetal rat hepatocytes. EMSA analysis with nuclear protein
extracts shows NF-B DNA binding activity in cells maintained in the presence or absence of TGF- (2 ng/ml). (G)Overexpression of p65 induces Snail1
upregulation, which is prevented by the IB super-repressor. A CMV-p65 expressing vector, ssIB vector or an empty vector (pcDNA3) was transfected into foetal
rat hepatocytes. After 36 hours, hepatocytes were stimulated with TGF- (2 ng/ml) for the times indicated. Snail1 mRNA levels were analyzed by quantitative RT-
PCR and the transcription was normalized to Gapdh mRNA levels. Bars represent the s.e.m.
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primary cultures, we used an immortalized cell line obtained from
neonatal murine hepatocytes (González-Rodríguez et al., 2008)
that responds to TGF- in a very similar way to that found in foetal
rat hepatocytes (our unpublished results) (supplementary material
Fig. S4). As expected, the induction of Snail1 by TGF- was
significantly reduced in the presence of siRNA for Snail1 (Fig.
3C), the downregulation of E-cadherin expression was impaired
and the EMT was prevented after 30 hours of treatment (Fig. 3A).
We used a second sequence to interfere with Snail1 expression,
obtaining similar results (siSnail-3; data not shown; see Materials
and Methods). TGF--treated control cells depicted a clear
apoptotic process (Fig. 3D,E) that produced cell death at later
times (Fig. 3B,F). Upon Snail downregulation, treatment with
TGF- induced a higher level of caspase 3 activity and apoptotic
nuclei (Fig. 3D,E) that gave rise to a massive cell death after 48
hours (Fig. 3B,F). Interestingly, at this time, the only hepatocytes
that survived were those showing a mesenchymal phenotype,
indicative of those that, albeit probably reduced, still had enough
levels of Snail and had finally undergone EMT (Fig. 3F; blue
arrows in Fig. 3B). To confirm that the massive cell death observed
in the presence of Snail1 siRNA was specifically due to Snail1
downregulation and to show that Snail1 could prevent the death
induced by TGF-, we carried out a rescue experiment by
transfecting cells with a construct containing the Snail1 coding
region (Snail1CD). This construct was able to prevent the cell
death induced by TGF- (Fig. 3G). We then designed a Snail1
siRNA specific for 3 untranslated sequences (siSnail1-3) so that
it could not target Snail1CD. siSnail-3 reduced Snail1 transcript
levels to around 50% (Fig. 3H). When Snail1CD was expressed
together with siSnail1-3, it very significantly attenuated the action
of the siRNA (Fig. 3G). This experiment (Fig. 3G,H) was carried
out cotransfecting Snail1CD and/or siSnail1-3 together with a
construct encoding GFP and all the calculations were made based
on green fluorescent cells to avoid the interference that
untransfected cells might have caused. These data confirm the
specificity of the Snail1 knockdown experiments and indicate that
Snail1 is sufficient to prevent the death induced by TGF- in
cultured hepatocytes.
In the presence of siRNA for Snail1, in addition to an increase
in cell death, we observed an earlier and stronger upregulation of
genes previously related to the apoptosis induced by TGF-, such
as the BH3-only genes Bim (Bcl2l11) and Bmf (Ramjaun et al.,
2007) (Fig. 4A,B). Interestingly, Snail1 interference is sufficient to
upregulate Bim expression, a BH3-only protein that responds to
the absence of survival signals in general, whereas the expression
of Bmf is significantly upregulated in response to TGF- when
3469Snail1 overcomes TGF--induced apoptosis
Fig. 2. Snail1 transcription requires NF-B
binding to the Snail1 proximal promoter in
FaO rat hepatoma cells. (A)Phase-contrast
images and immunofluorescence detection of
E-cadherin in FaO cells treated with TGF- (2
ng/ml). (B)RT-PCR analysis of endogenous
Snail1 expression in FaO cells, which were
either untreated or pretreated with SN50
(50M, 1 hour) and then stimulated with
TGF- (2 ng/ml; T) for 3 hours. The
expression of Gapdh was used as a control for
the amount of cDNA template in each sample.
(C)Knockdown of p65 with specific siRNA
(rat sip65-1) inhibits TGF--induced Snail1
upregulation. Cells were transfected with
either an unspecific siRNA (siControl) or the
sip65-1 (100 nM) and then treated with TGF-
(2 ng/ml), as described in the Materials and
Methods. Graphs represent real-time PCR for
the analysis of p65 (left) and Snail1 (right)
transcript levels. (D)NF-B regulates the
activity of the Snail1 promoter. Luciferase
reporter constructs carrying the wild-type
mouse Snail1 promoter (–1000 pb) or
deletions in the B-boxes were transfected into
FaO cells together with a CMV-p65 expression
vector or empty vector (pcDNA3) as a control.
Luciferase activity was assayed 40 hours after
transfection. Activity is expressed relative to
that of the wild-type construct. (E)NF-B is
recruited to the Snail1 promoter following
TGF- administration. FaO cells were
maintained in the presence or absence of TGF-
 (2 ng/ml) for 72 hours and processed for
chromatin immunoprecipitation (ChIP)
analyses as described in the Materials and
Methods. P50 refers to the anti-p50 antibody.
The experiment was repeated three times with
similar results.
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Snail is downregulated. TGF- can also induce anti-apoptotic
signals in foetal hepatocytes and liver tumour cells (Murillo et al.,
2005; Caja et al., 2009), mediating an increase in the intracellular
content of anti-apoptotic proteins of the Bcl2 family, BclxL and
Mcl1. A similar response was observed in this murine neonatal
liver cell line (Fig. 4C), a response that was impaired when Snail1
levels were decreased with siSnail1 (Fig. 4C). Indeed, Snail1
downregulation provokes changes in the TGF--mediated
regulation of BclxL and Mcl1, favouring the increase in the ratio
of the pro-apoptotic versus anti-apoptotic members. Coincident
with these changes in gene expression, the percentage of cells
exposed to TGF- with activated Bax or Bak significantly increased
in the presence of Snail1 siRNA, indicating that Snail1 can
counteract the mitochondrial-dependent apoptosis induced by TGF-
 in hepatocytes (Fig. 4D).
Having confirmed that Snail1 plays an important role in the
resistance to apoptosis induced by TGF-, we examined whether
it might also protect hepatocytes from death by anoikis. Indeed, a
decrease in Snail1 expression in immortalized murine hepatocytes
impaired the TGF--induced cell adhesion in the absence of
substrate. The number of adherent cells, reflecting their capacity to
attach to untreated plastic, only increased on exposure of control
hepatocytes to TGF- but not in those with diminished Snail1
expression (Fig. 5, left). Furthermore, when the cells that did not
adhere were plated on cell culture dishes to analyze their capacity
to survive for 48 hours in the absence of substrate, those cells
transfected with specific Snail1 siRNA were more susceptible to
die than control cells, both in the presence or absence of TGF-
(Fig. 5, right).
Snail1 activation induces EMT and prevents the apoptotic
effects of TGF- in adult hepatocytes
TGF- does not provoke an anti-apoptotic response in adult rat
hepatocytes and it fails to induce Snail1 expression and EMT in
these cells (Caja et al., 2007). Thus, we assessed whether the lack
of Snail1 activation was responsible for the deficient anti-apoptotic
response to TGF- by forcing Snail1 expression in adult
hepatocytes, in which it is normally silenced. Because adult
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Fig. 3. Snail1 downregulation enhances
the apoptotic response to TGF- in
immortalized murine hepatocytes. Cells
were transfected with either an unspecific
siRNA (siControl) or a Snail1 siRNA
(mouse siSnail1-1) and then treated with
TGF- (2 ng/ml) as described in the
Materials and Methods. (A)E-cadherin
expression in cell cultures fixed after 30
hours of TGF- treatment. (B)Micrographs
of similar cultures after 48 hours of TGF-
treatment. Arrows indicate examples of
cells that had undergone EMT. (C)Snail1
transcription levels, analyzed by real-time
PCR after 6 hours of TGF- treatment.
(D)Caspase 3 activity 30 hours after TGF-
 treatment, analyzed by fluorimetry and
presented as a percentage of the control.
(E)Apoptotic nuclei 30 hours after TGF-
treatment (percentage of condensed and/or
fragmented nuclei assessed by Hoechst
staining). (F)Cell viability after 48 hours
treatment, analyzed by Crystal Violet
staining and expressed as a percentage of
the control. (G)A plasmid containing the
coding region of Snail1 (Snail1CD) was
able to prevent TGF--induced cell death
and was also able to rescue the cell death
observed after Snail1 downregulation
(siSnail1-3). (H)Snail1 transcription
levels, analyzed by real-time PCR after 6
hours of TGF- treatment in the presence
or in the absence of siSnail3 and/or
Snail1CD. Data are means ± s.e.m. of at
least three independent experiments. In E,
10-15 different fields per condition were
counted in each experiment (n3).
(Student’s t-test: *P<0.05; **P<0.005;
***P<0.0005.)
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hepatocytes are very difficult to transfect in culture, we took
advantage of a conditional transgenic mouse line in which Snail1
could be activated by tamoxifen administration (Snail-ERT2) (De
Frutos et al., 2007; De Frutos et al., 2009) (see Materials and
Methods). We selected a line that expressed the transgenic protein
in the liver (Fig. 6A) enabling us to study a virtually homogeneous
population of hepatocytes that constitutively express exogenous
Snail1 protein. In these cells, the protein is sequestered in the
cytoplasm and it is thus inactive as a transcription factor. However,
it becomes active after nuclear translocation upon tamoxifen
administration (De Frutos et al., 2007; De Frutos et al., 2009; Feil
et al., 1996).
Hepatocytes obtained from these Snail1-ER transgenic mice
that were treated in vivo with tamoxifen adopted a mesenchymal
phenotype (not shown), as did primary hepatocyte cultures
established from untreated transgenic mice that were subsequently
exposed to tamoxifen (Fig. 6B). This phenotypic change indicates
that these cells had undergone a process of EMT following the
nuclear translocation of Snail1 in the presence of tamoxifen
(Fig. 6B). The Snail1-induced EMT was confirmed by the
downregulation of E-cadherin expression both at the mRNA and
the protein levels and by the reorganization of the F-actin
filaments to form lamellipodia and ruffles even in the absence of
TGF- (Fig. 6C,D). We then wondered whether these hepatocytes
were still able to respond to TGF- in terms of growth arrest by
examining the expression of the cell cycle inhibitor p21. We
found that TGF- can induce p21 transcription regardless of the
presence of activated Snail1, indicating that Snail1 overexpression
is not interfering with TGF- signalling and that TGF- can still
induce growth arrest independent of Snail1 expression (Fig. 6E).
Furthermore, TGF- was still able to interfere with the increase
in cell number mediated by a mitogenic stimulus (EGF plus
insulin) even in the presence of Snail1, although in this case, cell
numbers were maintained at the control level owing to the effect
of Snail1 in preventing cell death (Fig. 6F). The observation that
TGF- can still induce growth arrest in FaO rat hepatoma cells
in the presence of Snail1 siRNA as assessed in studies of BrdU
incorporation (not shown) also reinforces the idea that TGF-
can induce growth arrest independent of Snail1. Conversely,
although adult hepatocytes resist EMT in response to TGF-
(Caja et al., 2007), Snail1 activation is sufficient to elicit this
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Fig. 4. Snail1 downregulation increases the
mitochondrial-dependent apoptotic events. Cells
were treated as described in Fig. 3. (A,B)Analysis of
the levels of pro-apoptotic Bim and Bmf transcripts
by real time RT-PCR after 3 hours of TGF-
treatment. Data correspond to five independent
experiments. (C)Mcl1 and BclxL protein levels after
24 hours of TGF- treatment. (D)Percentage of cells
expressing the active form of Bax or Bak after 6
hours of TGF- treatment and analyzed by
immunofluorescence as described in the Materials
and Methods. Data are means ± s.e.m. of a
representative experiment (n3), where 25
independent fields per condition were counted.
(Student’s t-test: *P<0.05; **P<0.005; N.S., non-
significant.)
Fig. 5. Snail1 downregulation sensitizes immortalized murine hepatocytes
to cell death by anoikis. Cells were transfected with either a non-specific
siRNA (siControl) or a Snail1 siRNA (siSnail) as described in the Materials
and Methods and were then treated with TGF- (2 ng/ml) for 48 hours. Cells
were subsequently trypsinized and plated on bacteria dishes for 48 hours. Left:
Number of cells that adhered to the bacteria dishes (counted after Crystal
Violet staining), reflecting their capacity to attach on non-treated plastic. Data
are means ± s.e.m. of a representative experiment (n3; 25 independent fields).
Right: Cells that did not adhere to the bacteria dishes were later plated at
identical cell density on cell culture dishes. Viable cells were quantified after
48 hours (Crystal Violet staining and spectrophotometric analysis). siSnail
cells were sensitized towards apoptosis in the absence of cell adhesion
(anoikis). Data are means ± s.e.m. of a representative experiment (n3).
(Student’s t-test: **P<0.005; ***P<0.0005; N.S., non-significant.)
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response and induce the morphological and gene expression
changes associated with EMT. In addition to the EMT, striking
changes were also observed in the apoptotic response. As such,
caspase 3 activation was blocked when Snail1 was activated,
concomitant with the absence of apoptotic nuclei, and TGF-
was unable to induce cell death although tamoxifen affected the
basal levels of viable cells (Fig. 6G). These results indicate that
Snail1 is sufficient to protect hepatocytes from cell death induced
by TGF- even in the context of normal adult hepatocytes, which
are refractory to express Snail1.
Snail1 impairs the apoptotic effects of TGF- in
hepatocellular carcinoma cells
Once shown that Snail1 activation is sufficient to induce EMT and
protect adult hepatocytes from TGF--mediated cell death, we
wondered whether Snail1 could be responsible for the resistance
to TGF--induced apoptosis in human hepatocellular carcinoma
cells, which might be relevant for the progression of human liver
tumourigenesis (Fabregat, 2009). We used the Hep3B cell line,
which although maintaining the epithelial phenotype, respond much
less to TGF- in terms of apoptosis than adult hepatocytes (Caja
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Fig. 6. Snail1 activation induces EMT and
blocks the apoptotic effects of TGF- in adult
hepatocytes. (A)Snail1-ER fusion protein
detected in a section of embryo at 14.5 days post-
conception. High-power images of the liver show
the presence of Snail1-ER transgenic protein in
the cytoplasm of transgenic livers, evident as
brown staining of the anti-human estrogen
receptor antibody (hER). A photograph of a rib is
shown as a negative control of non-expressing
tissues. (B)Hepatocytes isolated from 2-month-
old Snail1-ER transgenic mice were either
untreated or treated with tamoxifen (TAM) for 72
hours and their response analyzed after a further
48 hours in the presence of TGF- (2 ng/ml).
Phase-contrast images showing the epithelial
(parenchymal) or mesenchymal phenotype of
hepatocytes, either treated or untreated with
TAM. TAM treatment was accompanied by an
efficient nuclear translocation of the Snail1-ER
transgenic protein as assessed by
immunoflourescence analysis with the same anti-
hER antibody as in A. (C)TGF- induces the
loss of E-cadherin expression and the
reorganization of the F-actin to form
lamellipodia and ruffles only in TAM-pretreated
hepatocytes and independent of TGF-
administration. (D,E)Analysis of E-cadherin and
p21 transcript levels by real time RT-PCR.
(F)TGF- impairs the mitogenic effect of
epidermal growth factor (EGF) even in the
presence of high levels of Snail1 expression. Ins,
insulin. (G)Effect on apoptosis after 48 hours of
treatment. Left: Caspase 3 activity analyzed
fluorimetrically. Results are expressed as the
mean ± s.e.m. percentage of their respective
controls from five independent experiments.
Middle: Percentage of apoptotic nuclei analyzed
by microscopy observation of condensed and/or
fragmented nuclei (Hoechst staining). A
representative experiment is shown and the mean
± s.e.m. of ten different fields is represented.
Right: Cell viability analyzed by Crystal Violet
staining and expressed as a percentage of their
respective control. Data are the mean ± s.e.m. of
four independent experiments, in duplicate.
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et al., 2009). They are also susceptible to express Snail1 and
undergo EMT in a similar way to foetal hepatocytes upon TGF-
exposure (our unpublished data). Without serum, Hep3B cells
show autocrine growth as they express survival signals that
attenuate TGF--induced cell death (Fig. 7A,B). By contrast, when
Snail1 was downregulated in these cells, TGF- was able to
efficiently induce cell death (Fig. 7A) as also assessed by the
increased levels of caspase 3 activation and the percentage of
apoptotic nuclei (Fig. 7B), which correlated with diminished levels
of Snail1 induction after TGF- administration (Fig. 7B). We then
tested SK-HEP1, a liver adenocarcinoma cell line that depicts a
late TGF- signature (Coulouarn et al., 2008), showing a
fibroblastic-like appearance, autocrine production of TGF- and
resistance to TGF--induced cell death (Fig. 7C,D). In these cells,
Snail1 downregulation promoted apoptotic features that were
enhanced in the presence of additional extracellular TGF-.
Altogether, these results indicate that malignant cells can
circumvent the death-inducing effect of TGF- by directing it
towards the induction of Snail1 expression, which promotes
survival and EMT.
Discussion
The complex and sometimes contrasting signals induced by TGF-
 in epithelial cells (Massagué, 2008; Zavadil and Bottinger, 2005;
Heldin et al., 2009) make it difficult to understand its specific role
in tumour progression. Indeed, its influence might even be cell-
context-specific and dependent on the extracellular environment.
In the case of the liver, recent findings have offered new insights
into the role of TGF- in human hepatocarcinogenesis. Indeed, its
clear tumour suppressor role evident at early stages is converted to
a tumour promoter function at advanced stages (Massagué, 2008).
Liver cancer cells become resistant to TGF--mediated cell death,
and they become capable of undergoing EMT and acquiring
invasive properties. Accordingly, liver tumours expressing an early
TGF- signature (suppressor genes) have a less invasive phenotype
and tumour recurrence when compared with those that express late
TGF--responsive genes (anti-apoptotic and metastatic) (Coulouarn
et al., 2008). Thus, it is crucial to understand the mechanisms that
permit liver cancer cells to escape from the suppressive effects of
TGF-, both to understand tumour progression and to design
therapies to block the pro-tumourigenic effects of TGF- in human
hepatocellular carcinoma. Here, we show that, as well as inducing
EMT, Snail1 overcomes the death-inducing effects of TGF- in
liver cells.
With respect to the induction of Snail1 expression by TGF-,
we show that it requires the nuclear translocation of the NF-B
transcription factor in foetal or tumoural hepatocytes and its binding
to the NF-B box2 (–162) in the proximal mouse Snail1 promoter.
This confirms the connection between NF-B and Snail
upregulation described in several cell lines (Barberá et al., 2004;
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Fig. 7. Snail1 downregulation restores the
apoptotic response to TGF- in human liver
tumour cells. Hep3B or SK-Hep1 cells were
transfected with either an unspecific siRNA
(siControl) or the specific Snail1 siRNA (human
siSna1-1), as described in the Materials and
Methods, and then were treated with TGF- (2
ng/ml). (A,C)Photographs of Hep3B, SK-Hep1
cell cultures (36 hours of TGF- treatment) from
one representative experiment of three. (B,D)In
all cases, cells were treated with TGF- over 24
hours. Left: Snail1 transcript levels analyzed by
real time RT-PCR after a 1-hour treatment with
TGF-. Middle: Caspase 3 activity was analyzed
by fluorimetry and presented as the percentage
of the controls. Right: Percentage of apoptotic
nuclei (microscopy observation of condensed
and/or fragmented nuclei after Hoechst staining;
15 independent fields/dish). Data are the means
± s.e.m. of at least three independent
experiments and they were compared as
indicated in the figure. (Student’s t-test:
*P<0.05; **P<0.005; ***P<0.0005; N.S., non-
significant.)
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Julien et al., 2007; Kim et al., 2007) and during development
(Zhang et al., 2006), and it is reminiscent of the recently described
binding of p65 to the snail1a promoter in zebrafish embryos (Liu
et al., 2009). Interestingly, other intracellular signals appear to be
dispensable, such as MEK/ERKs or PI3-K.
Snail1 is required for TGF--mediated EMT in hepatocytes
As mentioned above, in addition to becoming refractory to the
tumour-suppressor effects that lead to decreased cell proliferation
and cell death, tumour cells also respond to TGF- by undergoing
EMT, a phenotypic change associated with tumour invasion and
metastatic potential (Massagué, 2008; Thiery et al., 2009).
Conversely, blocking TGF- signalling upregulates E-cadherin,
reducing cell migration and the invasion of hepatocellular
carcinoma cells (Fransvea et al., 2008), indicative of a reversion
of the EMT process. Because Snail1 actively contributes to tumour
progression by inducing EMT and is a well-known target of TGF-
 signalling (Thiery et al., 2009), we examined whether Snail1
could provoke the EMT response observed in liver tumour cells
upon exposure to TGF-. Our data indicate that Snail1 does
indeed play an important role in regulating this phenotypic
transition as its silencing prevents the TGF--mediated E-cadherin
loss and EMT. Furthermore, forced activation of Snail1 is sufficient
to induce EMT in non-transformed adult hepatocytes that are
otherwise extremely refractory to such a transition, even in the
continued presence of TGF-. The failure to undergo EMT is
compatible with the failure of TGF- to induce Snail1 expression
(Caja et al., 2007). Thus, our data are consistent with adult tumour
cells being able to respond to TGF- by undergoing EMT as it
occurs in foetal hepatocytes (Valdés et al., 2002) and suggest that
a reactivation of developmental genes such as Snail1 in liver
tumour cells contributes to the pro-tumourigenic role of TGF-.
This is reminiscent of the EMT process that accompanies the
switch from the anti-inflammatory to the profibrogenic role of
TGF- observed during the progression of organ fibrosis.
Interestingly, this switch is also associated with the reactivation of
Snail1 expression and, likewise, forced Snail1 expression in normal
kidneys is sufficient to generate EMT and fibrosis, leading to
organ failure in transgenic mice (Boutet et al., 2006; López-Novoa
and Nieto, 2009). It will be interesting to define the mechanism
that prevents Snail1 upregulation in non-transformed adult
hepatocytes. Perhaps the susceptibility of cancer cells is related to
the presence of activated Ras, which is crucial for the TGF--
mediated induction of Snail1 expression and EMT in renal cells
as well as in hepatic and pancreatic cell lines (Gotzmann et al.,
2002; Peinado et al., 2003; Grande et al., 2009; Horiguchi et al.,
2009).
Snail1 confers resistance to TGF--induced cell death in
hepatocytes
In addition to preventing EMT, our data show that Snail1
downregulation significantly enhances the apoptotic response to
TGF- of liver cells. Conversely, Snail activation confers full
resistance to TGF--induced apoptosis in immortalized mouse
hepatocytes and in adult hepatocytes obtained from transgenic
mice. These results indicate that Snail1 coordinates the EMT with
cell survival signals in the liver, which is reminiscent of situations
taking place during embryonic development (Barrallo-Gimeno and
Nieto, 2005). Snail1 can also decrease cell death in cultured liver
cells not treated with TGF- when compared with control cells,
indicating that Snail not only protects from the death induced by
TGF-. Indeed, Snail family members are known to confer
resistance to the cell death induced by the removal of survival
signals, apoptotic stimuli, gamma radiation and genotoxic stress
(Inoue et al., 2002; Vega et al., 2004; Pérez-Losada et al., 2003;
Kajita et al., 2004; Vitali et al., 2008; Martínez-Álvarez et al.,
2004). Importantly, we show that Snail is required to overcome the
cell death induced by TGF-.
We also show that Snail1 downregulation induces an earlier and
stronger activation of Bim and Bmf by TGF-, two pro-apoptotic
BH3-only members of the Bcl2 family, and it impairs the TGF--
induced increase in the anti-apoptotic BclxL and Mcl1. This
indicates that Snail1 might antagonize TGF--induced apoptosis
by repressing pro-apoptotic genes of the Bcl-2 family that are
essential for TGF- to induce an efficient mitochondrial-mediated
apoptosis (Ramjaun et al., 2007) and by upregulating the anti-
apoptotic members of the family. As Snail factors have been
described as strong transcriptional repressors, the positive action
of Snail on the expression of anti-apoptotic factors is very likely
to be indirect, although the possibility of Snail acting as a direct
activator cannot be formally excluded. These effects might be
connected with the known function of another Snail family member,
Snail2, in antagonizing p53-mediated apoptosis of haematopoietic
progenitors by repressing Puma transcription (Wu et al., 2005).
Indeed, the effects of Snail downregulation that we have seen in
hepatocytes are similar to those observed after Puma expression in
myeloid progenitor cells, including Bax activation (Jabbour et al.,
2009). Additionally, our results showing that Snail1-targeted
knockdown impairs the TGF--mediated increase in BclxL and
Mcl1, indicate that Snail1 can indirectly activate intracellular
survival signals, perhaps because the increase in their levels in
hepatocytes exposed to TGF- occurs concomitant with the
activation of the PI3-K/Akt pathway (Valdés et al., 2004). These
data are also compatible with the effects of Snail1 transfection in
epithelial kidney MDCK cells, where it increases the expression of
BclxL and the activity of the PI3-K/Akt and MEK/ERK survival
pathways (Vega et al., 2004). In addition, we show that Snail1 can
also control hepatocyte adhesion and confer resistance to the
apoptosis induced by loss of contact (i.e. anoikis). This effect
confirms and expands previous data showing that Snail1 regulates
cell attachment to the extracellular matrix (Haraguchi et al., 2008)
and with recent data supporting a role for a Twist-Snail axis in the
TrkB-induced EMT and anoikis resistance in rat intestinal epithelial
cells (Smit et al., 2009).
Snail1 overcomes the death-inducing effects of TGF- in
liver cancer cells
As a consequence of the failure of liver carcinoma cells to respond
to the death-promoting effect of TGF-, and given their ability to
respond in terms of undergoing EMT, hepatoma cells overcome
the TGF- tumour-suppressor effects. We show here that, in human
hepatocellular carcinoma cell lines, Snail1 downregulation restores
the capacity of cells to respond to TGF- by undergoing apoptosis,
the most important role of TGF- in controlling hepatocellular
carcinoma progression. Indeed, Smad3, a physiological mediator
of TGF- tumour-suppressor activity, functions by repressing Bcl2
expression and inducing apoptosis (Yang et al., 2006). Interestingly,
Snail1 acts in an opposite way by increasing BclxL and Mcl1
expression. As Smad3 is also necessary for the TGF--induced
Snail1 expression (Sato et al., 2003), the final cellular response
and perhaps hepatocellular carcinoma progression might depend
on the equilibrium between the activation of these two Smad3
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targets, Bcl2 and Snail1. As Snail1 can recruit Smad3 to repress
the promoters of several epithelial genes, including that of E-
cadherin (Vincent et al., 2009), it would be interesting to investigate
whether, by sequestering Smad3, Snail1 could also prevent Smad3
from repressing Bcl2, switching the response to TGF- from cell
death to survival and EMT.
In summary, we show here that Snail1 overcomes the apoptosis
induced by TGF-, as occurs in immature liver and
hepatocarcinoma cells that respond to this factor, by expressing
Snail1 and undergoing EMT. Furthermore, forced Snail1 expression
is sufficient to induce EMT and protection from undergoing
apoptosis in non-transformed adult hepatocytes. It is worth noting
here that adult hepatocytes are normally refractory to activate
Snail1 and undergo EMT even in the presence of TGF-. These
data indicate that the reactivation of developmental genes in the
adult impinges on their response to cytokines that might initially
be released as a healing response, such as TGF-. This has
important implications in degenerative organ disease, and in
particular in tumour cells, where TGF- activates Snail1 to switch
the response towards the induction of EMT, thereby promoting
invasive and metastatic properties. As Snail1 has also been
associated with resistance to conventional chemotherapy (Thiery
et al., 2009), its role in preventing cell death in the liver might have
important implications in cancer progression and treatment.
Together, our work points to a role of Snail1 in overcoming TGF-
 tumour-suppressor effects in hepatocytes, and particularly in
liver cancer cells, switching the response from tumour suppression
to tumour progression, making them resistant to cell death and
prone to undergo EMT and acquire invasive properties.
Materials and Methods
Materials
Human recombinant TGF-1 was obtained from Calbiochem (La Jolla, CA) and
foetal bovine serum (FBS) was obtained from Sera Laboratories International (Cinder
Hill, UK). The primary monoclonal anti-vimentin and anti--actin antibodies, as
well as Rhodamine-conjugated phalloidin, were from Sigma-Aldrich (St Louis,
MO). Antiphospho-Smad2 (Ser465/467) was from Cell Signalling Technology
(Beverly, MA) and the monoclonal anti-E-cadherin, anti-Bax antibody 6A7 clone
and anti-Bak G317-2 clone were from BD Transduction Laboratories (Erembodegem,
Belgium). The anti-human oestrogen receptor (hER), the polyclonal anti-Mcl1 (S-19)
and anti-BclX (S-18) were from Santa Cruz Biotech. Inc (Santa Cruz, CA). The
Cy3-conjugated anti-rabbit and Green Oregon-conjugated anti-mouse secondary
antibodies were from DAKO (Glostrup, Denmark). Alexa Fluor-488-conjugated
anti-rabbit and anti-mouse immunoglobulin was from Molecular Probes (Eugene,
OR). Cycloheximide, rapamycin, SB431542 and SB203580 were all obtained from
Sigma-Aldrich, whereas LY294002 and SP600125 were from Alexis Biochemicals
(Lausen, Switzerland). AG1478, PD98059 and SN-50 were purchased from
Calbiochem. The ssIB expression vector carrying mutated Ser 32 and Ser 36 to
prevent phosphorylation and proteolysis of IB was generously provided by Dra
Mónica A. Costas (Werbajh et al., 2000).
Cell isolation and culture
Foetal rat hepatocytes were obtained by collagenase disruption of 20-day-old foetal
Wistar rat liver and they were cultured in uncoated plastic dishes with arginine-free,
ornithine-supplemented M 199 medium as described previously (Roncero et al.,
1989). Adult murine hepatocytes were isolated by collagenase perfusion of mouse
livers as described elsewhere (Kao et al., 1996). Briefly, anesthetized mice were
subjected to liver perfusion with 50 ml of a 0.02% (w/v) collagenase in Hanks
Balanced Salt Solution through the vena cava at a rate of 2.5 ml/minute using a
peristaltic pump. The liver tissue was processed mechanically, passed through a 70
m filter and resuspended in an isotonic Percoll solution. After centrifugation, the
cells were seeded at 0.25106 cells in 6-well dishes in DMEM/F:12 (1:1)
supplemented with 10% FBS. Immortalized neonatal murine hepatocytes were
generously provided by Angela M. Valverde (Madrid, Spain), obtained as previously
described (González-Rodríguez et al., 2008). In primary cultures, the serum was
removed after cell attachment and 12–14 hours later, TGF- was added. In the case
of immortalized neonatal hepatocytes, TGF- treatment was initiated after 4 hours
serum starvation. In all cases, inhibitors were added 30 minutes before TGF-. FaO
rat hepatoma cells and Hep3B human negroid hepatocyte carcinoma cells were
obtained from the European Collection of Cell Cultures (ECACC), cultured in
DMEM supplemented with 10% FBS and maintained in a humidified atmosphere of
37°C, 5% CO2. For experiments, cells at 70% confluence were serum-starved for 8–
12 hours before treatments.
Primary cultures from transgenic mice
The Snail-ERT2 construct (De Frutos et al., 2007; De Frutos et al., 2009) was
microinjected into fertilized C57CBA hybrid eggs to generate transgenic mice
according to Hogan et al. (Hogan et al., 1994). A line expressing the transgenic
protein in the liver was selected (Fig. 6A). Two-month-old mice were sacrificed by
cervical dislocation and their livers were dissected out and cultured as described
above. Cells were cultured in the presence or absence of 200 nM 4OH-tamoxifen.
Real-time PCR
Total RNA was obtained using the RNeasy Kit (Qiagen, Hilden, Germany) and
complementary DNA was generated by the SuperScript First-Strand Synthesis
System for RT-PCR (Invitrogen, Carlsbad, CA) using oligo (dT) as the primer.
Quantitative RT-PCRs were carried out by two different methods. (1) Step One Plus
(Applied Biosystems, Carlsbad, CA) sequence detection system, using the SYBR
Green method. RNA expression was calculated using the comparative Ct method
normalized to GAPDH. For cell culture experiments, data were normalized using the
C0 ± s.d. formula to compare the relative expression between the different genes. The
data are represented as the mean ± s.d. of the different experiments, each examined
in triplicates (n3). Specific primers for mouse and rat sequences used were as
follows: Gapdh 5-CTGAGCAAGAGAGGCCCTATCC-3 (forward), 5-CTCCC -
TAG GCCCCTCCTGTT-3 (reverse); Snail1 5-CCACACTGGTGAGAAGCCA -
TTC-3 (forward), 5-TCTTCACATCCGAG -TGGGTTTG-3 (reverse); p21
5-AG G AG CCAGGCCAAGATGGT-3 (forward), 5-GCTTTGACACCCA CG -
GTATTCA-3 (reverse); Ecdh 5-ACCTCCG TGATGAAGGTCTC-3 (forward), 5-
CCGGTGTCCCTATTGACAGT-3 (reverse). (2) ABIPrism7700 System, following
the manufacturer’s protocol and using pre-designed Taqman primers: Rat – p65
Rn01502266_m1, Gapdh Rn99999916_s1; Mouse – 18S Hs03003631_g1, Bcl2l11
Mm00437796_m1 (Bim), Bmf Mm00506773_m1; Human – Snai1 Hs00195591_m1;
18S Hs03003631_g1.
Western blot analysis
Total protein extracts and western blot analysis were performed as described
previously (Murillo et al., 2005).
Electromobility shift assay (EMSA)
A specific probe for DNA-protein interaction analysis was used, containing a nuclear
factor-kappaB (NF-B) binding element. The sequence that corresponded to the
NF-B motif in the iNOS promoter was as follows: 5-tcgaCCAACTGGGACT -
CTCCCTTTGGGAACA-3 (forward), 5-tcga TGT TC CCAAA GGGAGAGTCC -
CAGTTGG-3 (reverse). After annealing each forward and reverse oligonucleotide,
0.5 g were radiolabelled using the Klenow enzyme (Roche, Mannheim, Germany)
and (32P) dCTP (GE Healthcare, Chalfont St. Giles, UK). Radiolabelled
oligonucleotides were purified on MicroSpin SC-200 HR columns (GE Healthcare)
and used as probes. Radiolabelling was measured by liquid scintillation counting.
Nuclear extracts and EMSA experiments were performed as described previously
(Murillo et al., 2007). For specificity controls, 10 g of protein extract were incubated
for 15 minutes at 4°C with an anti-p65 antibody (2 g) or with unlabelled
oligonucleotide (100 ng), as indicated. Gels were dried and the complexes were
visualized by autoradiography.
Immunohistochemistry and immunofluorescence microscopy studies
Fluorescence microscopy studies were performed as described previously (Caja et
al., 2007). To stain F-actin, cells were fixed with 4% paraformaldehyde in PBS for
30 minutes at room temperature and incubated with Rhodamine-conjugated phalloidin
(1:500) diluted in 0.1% BSA for 1 hour. To detect E-cadherin and vimentin, the cells
were fixed with cold methanol for 2 minutes. Primary antibodies (1:50) were diluted
in 1% BSA and incubated for 2 hours at room temperature. After several washes with
PBS, the samples were incubated with fluorescent-conjugated secondary antibodies
for 1 hour at room temperature (1:500 for Cy3 conjugated anti-rabbit, 1:200 for
Alexa-Fluor-488-conjugated anti-rabbit and 1:200 for Oregon-Green-conjugated
anti-mouse immunoglobulins) and mounted in Vectashield with DAPI (Vector
Laboratories, Burlingame, CA). The blue signal represents the nuclear DNA stained
with DAPI. Representative images were taken with a Spot 4.3 digital camera and
software and edited in Adobe Photoshop. For analysis of apoptotic nuclei after DAPI
staining, fragmented and/or pyknotic nuclei were counted. Cells were visualized in
an Olympus BX-60 or a Leica DMR microscope with the appropriate filters.
Histological sections were obtained from embryos fixed in 4% paraformaldehyde
in PBS and embedded in paraffin. The presence of the human estrogen receptor was
detected with an -hER antibody (1:200; Santa Cruz). Immunodetection in embryo
sections was carried out either with the biotin-streptavidin system (ABC kit, Pierce)
or with an anti-rabbit Alexa-Fluor-488 (1/5000; Molecular Probes) in hepatocytes in
culture.
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Transient transfection and promoter analysis
Foetal hepatocytes
Foetal rat hepatocytes were cotransfected with 2 g of total DNA (400 ng of CMV-
Rel A or 400 ng of ssIB plasmid or an empty pcDNA3 vector and 800 ng of
pmSnail-Luc vector). A Renilla luciferase plasmid was also cotransfected as a control
of efficiency. Transient transfection were performed with JET PEI (Genycell Biotech,
Granada, Spain) following the manufacturer’s instructions in DMEM/F:12 (1:1)
supplemented with 5% FBS overnight. The medium was replaced by 2% FBS
DMEM/F:12 and 8 hours later was replaced by a serum-free medium. Twelve hours
later, hepatocytes were stimulated with TGF- (2 ng/ml). Luciferase and Renilla
activities were assayed using a Dual-Luciferase Reporter Assay System Kit (Promega
Biotech Iberica, Madrid, Spain) according to the manufacturer’s instructions. The
results are presented as a percentage of luciferase activity relative to controls
(luciferase values in cells cotransfected with empty vectors). Three independent
experiments were carried out.
Cell lines
The mouse Snail promoter sequence containing 1 Kb upstream of the ATG was
amplified by PCR from genomic mouse DNA using the following primers: 5-
CCGGTACCTGTGAACGTTCCAACACGAT-3 (forward; containing the KpnI site),
5-CCAAGCTTGTTGGCCAGAGCGACCTAGG-3 (reverse; containing the HindIII
site). The purified PCR product was subcloned into the pGL3-basic vector (Promega
Biotech Iberica) and the Quickchange Site-Directed Mutagenesis Kit (Stratagene,
Cedar Creek, Texas) was used to delete the b-boxes present in the mouse Snail1
promoter. FaO cells were transfected with 50 ng of CMV-Rel A or an empty
pcDNA3 vector and 400 ng of pmSnail1-Luc vector with control or mutated b sites.
A Renilla luciferase plasmid was also cotransfected as a control of efficiency.
Transfections were carried out using Lipofectamin (Roche Diagnostics, Barcelona,
Spain) and JET PEI (Genycell Biotech., Granada, Spain). The medium was replaced
24 hours after transfection by a serum-free F12 Coon’s Modified Medium and 12
hours later the cells were stimulated with TGF- (2 ng/ml). Luciferase and Renilla
activities were assayed as described above. The results are presented as a percentage
of luciferase activity relative to controls (luciferase values in cells cotransfected with
empty vectors).
ChIP assays
FaO cells (8106) were exposed to TGF- (2 ng/ml) for 72 hours or they were left
untreated, then were crosslinked with formaldehyde and washed twice with PBS.
The cell pellet was lysed and sonicated to shear the chromatin to an average length
of 0.5–1 kb. After centrifugation, 1% of the extract was aliquoted and used as the
total input control. The remaining extracts were precleared with protein A-agarose
and divided equally between three tubes containing agarose-conjugated p50; agarose-
conjugated normal goat IgG, used as a negative control; and anti-acetylated H3, used
as a positive control (Santa Cruz Biotechnology). Samples were incubated overnight
at 4°C with rotation. The purified DNA was suspended in 30 l of water. A 200 pb
fragment of the rat Snail promoter containing the conserved B-box was amplified
with the primers: 5-CTATTGGCGCAATCTTGA-3 (forward) and 5-CGCAA -
GGTCGGTAGACAACTC-3 (reverse). A more distal 200 pb fragment of the
promoter carrying the non-conserved B-box was amplified with the primers 5-
CACCAACCTCATCCTGGG-3 (forward); 5-ACAGCTGTGA CCG TCAATGGA-
3 (reverse).
Apoptosis studies
Cell protein extraction and fluorimetric analysis of caspase 3 activity were performed
on 10–20 g protein as described previously (Murillo et al., 2005). Fluorescence was
measured with an Optima Fluostar Microplate Fluorescence Reader. Final caspase 3
activity was expressed as fluorescence units/hour/mg protein. Protein concentration
was measured using the Bio-Rad (Hercules, CA) protein reagent. After DAPI
staining, apoptotic nuclei were quantified via those with a fragmented and/or pyknotic
appearance. To analyze cell attachment on plastic and for anoikis studies,
immortalized murine hepatocytes were transfected with either a non-specific siRNA
or the specific Snail1 siRNA and they were treated with TGF- (2 ng/ml) for 48
hours. Cells were subsequently trypsinized and plated on bacterial dishes for 48
hours. After this time, analysis of the number of cells that adhered to the bacterial
dishes reflected their capacity to attach to untreated plastic. Cells that did not adhere
to the bacteria dishes were later plated, at identical cell density, on cell culture
dishes. Only the cells surviving after 48 hours in the absence of adhesion could
attach to the dish. The viable cell number was quantified by Crystal Violet (0.2% in
2% ethanol) staining and spectrophotometric analysis of cell lysates, as described
previously (Valdés et al., 2002). The percentage of viable cells that remained was
calculated from the absorbance relative to that of control cells (incubated in the
absence of growth factors). To determine the percentage of cells containing active
Bax or Bak, cells were plated on gelatin-coated glass coverslips and the monolayer
was washed with PBS before the cells were fixed with 4% paraformaldehyde in PBS
for 30 minutes at room temperature. The cells were incubated for 2 minutes with
0.1% Triton X-100 and then with anti-Bax 6A7 clone and anti-Bak G317-2 clone
antibodies (1:50), diluted in 1% BSA and incubated overnight at 4°C. After several
washes with PBS, the samples were incubated with fluorescent-conjugated secondary
antibodies (1:200 for Alexa-Fluor-488-conjugated anti-rabbit) for 1 hour at room
temperature and embedded in Vectashield with DAPI (Vector Laboratories,
Burlingame, CA). The cells were visualized on an Olympus BX-60 microscope with
the appropriate filters and the DAPI nuclear DNA staining was apparent in blue.
Representative images were taken with a Spot 4.3 digital camera and the images
processed according to the instructions provided by the journal. The results are
shown as the percentage of positive cells relative to the total cell number.
Snail1 interference assays
For transient siRNA transfection, cells at 30% confluence were transfected over
18 hours using TransIT-siQuest (Mirus, Madison, WI) at a 1:300 dilution in
complete medium according to the manufacturer’s recommendation. After a further
24 hours of incubation in complete medium, the FBS concentration was decreased
to 2% and TGF- was added 4 hours later. Interference oligonucleotides were
obtained from Sigma-Genosys (Suffolk, UK) and assessed as previously described
(de Frutos et al., 2007). After control experiments with different siRNAs that gave
similar results, we chose the next sequences: Mouse siSnail1-1 5-CAAACCCA -
CUCGGAUGUGAAGAGAU-3 (used at 50 nM); Mouse siSnai1-3 5-
CAGCUGCUUCGAGCCAUAGAACUAA- 3 (used at 200 nM); Human siSna1-1
5-UCCCAGAUGAGCAUUGGCAGCGAGG-3 (used at 50 nM); Human siSna-2
5-CCACAGGACUUUGAUGAAGACCAUU-3 (used at 100 nM); Rat sip65-1
5-CUCAAGAUCUGCCGAGUAA-3 (used at 100 nM); Rat sip65-2 5-CGC -
AAAAGGACCUACGAGA-3 (used at 100 nM). Control siRNA was as previously
described (Sancho et al., 2006).
Rescue experiments
Cells were transfected using the Magnet Assisted Transfection System (IBA
BioTAGnology, Göttingen, Germany), either with a pEGFP-C3 plasmid alone or in
combination with a pcDNA3 plasmid containing the mouse Snail1 coding region
(CD), following manufacturer’s instructions. Briefly, a mixture of MATra A Reagent
and DNA in a ratio 1 l reagent:1 g DNA was added to the cell culture and
incubated for 15 minutes on a magnet plate. After 8 hours, Snail interference was
performed as described above.
Statistical analysis
ANOVA and Student’s t-test were used to analyze the differences between two
groups of data.
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